3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
19
Thyroid Neoplasms
7
Glioma
6
Thyroid Carcinoma, Anaplastic
5
Multiple Myeloma
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Thyroid Cancer, Papillary
3
Hematologic Neoplasms
3
Skin Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Histiocytosis, Langerhans-Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Adenocarcinoma, Follicular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid cancer, follicular
1
Thyroid cancer, Hurthle cell
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Sarcoma
1
Interventions
Imatinib Mesylate
12
Sunitinib
10
ripretinib
5
regorafenib
4
Blood Specimen Collection
3
envafolimab
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
Biopsy
2
trastuzumab deruxtecan
1
spartalizumab
1
ribociclib
1
pemigatinib
1
palbociclib
1
olverembatinib
1
nilotinib
1
guadecitabine
1
binimetinib
1
avelumab
1
avapritinib
1
atezolizumab
1
apatinib
1
Temozolomide
1
TAS-116
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
dabrafenib
×
1 year
×
Clear all
No trials found.